Among European patients with severe asthma, significant clinical heterogeneity and substantial disease burden exist despite advanced therapy.

Standardized imaging and histologic criteria can identify pulmonary fibrosis in children with ILD and guide treatment recommendations.

The FDA has accepted a New Drug Application for ralinepag, an investigational oral prostacyclin IP receptor agonist for pulmonary arterial hypertension.

Higher diet quality is associated with better lung function, especially among individuals with asthma or COPD.

Cannabis use remains high among young adults in the United States, according to a recent report issued by the University of Michigan.

In children and adolescents with signs of pulmonary embolism, PERC-Peds may safely rule out a diagnosis without testing or imaging.

Early tracheostomy may reduce in-hospital mortality among high-risk patients with sepsis requiring mechanical ventilation.

Study findings suggest lung aeration and gas exchange evolution is similar in SGA and AGA infants with moderate to severe BPD.

Kenvue launches Zyrtec Allergen Shield Spray, a drug-free OTC nasal mist for the relief of mild symptoms associated with allergic rhinitis.

Results were announced from the phase 3 study evaluating trastuzumab deruxtecan as a first-line treatment of patients with metastatic NSCLC.

A record share of US kindergartners started school last year without at least 1 required vaccine, with most claiming nonmedical exemptions.

Patients screened for lung cancer who reported baseline symptoms were more likely than asymptomatic patients to be diagnosed with lung cancer within 1 year.